Debu Tripathy on Hormonal Therapy for Breast Cancer
Debu Tripathy, MD, chair, Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center, discusses hormonal therapy for advanced and early-stage breast cancer.
Debu Tripathy, MD, chair, Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center, discusses hormonal therapy for advanced and early-stage breast cancer.
About two-thirds of all breast cancers make hormone receptors, which can cause changes in the expression of genes and lead to cell growth. Hormone therapy interrupts the hormone action and slows or stops the growth of hormone-sensitive tumors.
Hormone therapy can put patients with advanced breast cancer into remission or keep their disease from progressing for years, Tripathy says.
In early-stage breast cancers, hormone therapy can help prevent metastatic recurrences.
Tamoxifen is typically used for premenopausal patients with breast cancer and aromatase inhibitors are used for postmenopausal patients. Tripathy says that patients at higher risk seem to benefit from longer durations of hormonal therapy.
Oncology Nurses Provide Patients an Avenue to Supportive Care
November 12th 2019Palliative care is often associated with a patient entering end of life treatment and giving up on their treatment, but that isn't the reality of what id can do for patients. And oncology nurses can help guide patients to the right supportive care for them.
Hyman B. Muss Discusses the Importance of Nurses in Treating Pregnant Women With Breast Cancer
March 23rd 2016Hyman B. Muss, MD, professor of medicine at the University of North Carolina School of Medicine, discusses the vital roles that nurses play when it comes to treating pregnant women with breast cancer.
Kimberly J. Van Zee on Nomograms Helping in DCIS Treatment Decision-Making
March 18th 2016Kimberly J. Van Zee, MS, MD, FACS, attending surgeon at Memorial Sloan Kettering Cancer Center, discusses the institution's newly-developed nomogram that can help women make treatment decisions about ductal carcinoma in situ (DCIS).
